104 related articles for article (PubMed ID: 2328790)
21. [Clinical features and prognostic analysis of 75 primary myelofibrosis patients].
Yu Q; Xu L; Gao X; Xu W; Yan H; Wu W; Li J; Shen Z
Zhonghua Xue Ye Xue Za Zhi; 2014 Oct; 35(10):922-5. PubMed ID: 25339331
[TBL] [Abstract][Full Text] [Related]
22. The European Consensus on grading of bone marrow fibrosis allows a better prognostication of patients with primary myelofibrosis.
Gianelli U; Vener C; Bossi A; Cortinovis I; Iurlo A; Fracchiolla NS; Savi F; Moro A; Grifoni F; De Philippis C; Radice T; Bosari S; Lambertenghi Deliliers G; Cortelezzi A
Mod Pathol; 2012 Sep; 25(9):1193-202. PubMed ID: 22627739
[TBL] [Abstract][Full Text] [Related]
23. Risk factors and a prognostic model for postsplenectomy survival in myelofibrosis.
Tefferi A; Mudireddy M; Gangat N; Hanson CA; Ketterling RP; Pardanani A; Nagorney DM
Am J Hematol; 2017 Nov; 92(11):1187-1192. PubMed ID: 28782256
[TBL] [Abstract][Full Text] [Related]
24. A clinical-molecular prognostic model to predict survival in patients with post polycythemia vera and post essential thrombocythemia myelofibrosis.
Passamonti F; Giorgino T; Mora B; Guglielmelli P; Rumi E; Maffioli M; Rambaldi A; Caramella M; Komrokji R; Gotlib J; Kiladjian JJ; Cervantes F; Devos T; Palandri F; De Stefano V; Ruggeri M; Silver RT; Benevolo G; Albano F; Caramazza D; Merli M; Pietra D; Casalone R; Rotunno G; Barbui T; Cazzola M; Vannucchi AM
Leukemia; 2017 Dec; 31(12):2726-2731. PubMed ID: 28561069
[TBL] [Abstract][Full Text] [Related]
25. Comparison of prognostic scoring systems in primary myelofibrosis.
Morel P; Duhamel A
Blood; 2010 Jan; 115(3):745; author reply 745-6. PubMed ID: 20093412
[No Abstract] [Full Text] [Related]
26. An accurate, simple prognostic model consisting of age, JAK2, CALR, and MPL mutation status for patients with primary myelofibrosis.
Rozovski U; Verstovsek S; Manshouri T; Dembitz V; Bozinovic K; Newberry K; Zhang Y; Bove JE; Pierce S; Kantarjian H; Estrov Z
Haematologica; 2017 Jan; 102(1):79-84. PubMed ID: 27686378
[TBL] [Abstract][Full Text] [Related]
27. Monocytosis is an adverse prognostic factor for survival in younger patients with primary myelofibrosis.
Elliott MA; Verstovsek S; Dingli D; Schwager SM; Mesa RA; Li CY; Tefferi A
Leuk Res; 2007 Nov; 31(11):1503-9. PubMed ID: 17397921
[TBL] [Abstract][Full Text] [Related]
28. Prognosis in transplant-eligible patients with agnogenic myeloid metaplasia: a simple CBC-based scoring system.
Dingli D; Schwager SM; Mesa RA; Li CY; Tefferi A
Cancer; 2006 Feb; 106(3):623-30. PubMed ID: 16369987
[TBL] [Abstract][Full Text] [Related]
29. A prognostic classification of myelofibrosis with myeloid metaplasia.
Barosi G; Berzuini C; Liberato LN; Costa A; Polino G; Ascari E
Br J Haematol; 1988 Dec; 70(4):397-401. PubMed ID: 3219290
[TBL] [Abstract][Full Text] [Related]
30. Primary myelofibrosis: 2017 update on diagnosis, risk-stratification, and management.
Tefferi A
Am J Hematol; 2016 Dec; 91(12):1262-1271. PubMed ID: 27870387
[TBL] [Abstract][Full Text] [Related]
31. Myelofibrosis with myeloid metaplasia in young individuals: disease characteristics, prognostic factors and identification of risk groups.
Cervantes F; Barosi G; Demory JL; Reilly J; Guarnone R; Dupriez B; Pereira A; Montserrat E
Br J Haematol; 1998 Aug; 102(3):684-90. PubMed ID: 9722294
[TBL] [Abstract][Full Text] [Related]
32. Peripheral blood CD34 count in myelofibrosis with myeloid metaplasia: a prospective evaluation of prognostic value in 94 patients.
Arora B; Sirhan S; Hoyer JD; Mesa RA; Tefferi A
Br J Haematol; 2005 Jan; 128(1):42-8. PubMed ID: 15606548
[TBL] [Abstract][Full Text] [Related]
33. Associations and prognostic interactions between circulating levels of hepcidin, ferritin and inflammatory cytokines in primary myelofibrosis.
Pardanani A; Finke C; Abdelrahman RA; Lasho TL; Tefferi A
Am J Hematol; 2013 Apr; 88(4):312-6. PubMed ID: 23450619
[TBL] [Abstract][Full Text] [Related]
34. Increased mean platelet volume (MPV) is an independent predictor of inferior survival in patients with primary and secondary myelofibrosis.
Lucijanic M; Mitrovic Z; Cicic D; Prka Z; Pejsa V; Livun A; Stoos-Veic T; Romic Z; Zivkovic M; Lucijanic I; Fabris Z; Kusec R
Int J Hematol; 2018 Feb; 107(2):166-172. PubMed ID: 29022201
[TBL] [Abstract][Full Text] [Related]
35. Osteomyelosclerosis with thalassemia trait: report of a rare association, study of platelet function tests and review of literature.
Singh DK; Mahajan D; Nigam S; Singh T
Hematology; 2008 Apr; 13(2):83-7. PubMed ID: 18616873
[TBL] [Abstract][Full Text] [Related]
36. Idiopathic primary osteo-myelofibrosis: a clinico-pathological study on 208 patients with special emphasis on evolution of disease features, differentiation from essential thrombocythemia and variables of prognostic impact.
Thiele J; Kvasnicka HM; Werden C; Zankovich R; Diehl V; Fischer R
Leuk Lymphoma; 1996 Jul; 22(3-4):303-17. PubMed ID: 8819080
[TBL] [Abstract][Full Text] [Related]
37. [A study of prognostic value of cytogenetics in patients with primary myelofibrosis].
Li B; Xu J; Xu Z; Li C; Qin T; Fang L; Zhang H; Hu N; Pan L; Qu S; Wang J; Zhang Y; Zhang P; Xiao Z
Zhonghua Xue Ye Xue Za Zhi; 2014 Nov; 35(11):990-4. PubMed ID: 25417875
[TBL] [Abstract][Full Text] [Related]
38. Frequency and risk factors for thrombosis in idiopathic myelofibrosis: analysis in a series of 155 patients from a single institution.
Cervantes F; Alvarez-Larrán A; Arellano-Rodrigo E; Granell M; Domingo A; Montserrat E
Leukemia; 2006 Jan; 20(1):55-60. PubMed ID: 16307011
[TBL] [Abstract][Full Text] [Related]
39. Identification during the follow-up of time-dependent prognostic factors for the competing risks of death and blast phase in primary myelofibrosis: a study of 172 patients.
Morel P; Duhamel A; Hivert B; Stalniekiewicz L; Demory JL; Dupriez B
Blood; 2010 Jun; 115(22):4350-5. PubMed ID: 20308601
[TBL] [Abstract][Full Text] [Related]
40. Primary myelofibrosis: 2014 update on diagnosis, risk-stratification, and management.
Tefferi A
Am J Hematol; 2014 Sep; 89(9):915-25. PubMed ID: 25124313
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
